

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 8.07368759 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.65259517 |
| 3 | regulation of bile acid biosynthetic process (GO:0070857) | 7.52394759 |
| 4 | adhesion of symbiont to host cell (GO:0044650) | 6.84314807 |
| 5 | virion attachment to host cell (GO:0019062) | 6.84314807 |
| 6 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.36858736 |
| 7 | bile acid and bile salt transport (GO:0015721) | 6.22817318 |
| 8 | vitamin A metabolic process (GO:0006776) | 6.06454852 |
| 9 | actin filament depolymerization (GO:0030042) | 6.01348202 |
| 10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.87186610 |
| 11 | epoxygenase P450 pathway (GO:0019373) | 5.80397077 |
| 12 | fructose metabolic process (GO:0006000) | 5.78134243 |
| 13 | digestive system process (GO:0022600) | 5.54313236 |
| 14 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.53803336 |
| 15 | positive regulation of pseudopodium assembly (GO:0031274) | 5.45272329 |
| 16 | adhesion of symbiont to host (GO:0044406) | 5.43810898 |
| 17 | drug catabolic process (GO:0042737) | 5.09199995 |
| 18 | regulation of cGMP biosynthetic process (GO:0030826) | 4.93128258 |
| 19 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.92961870 |
| 20 | regulation of pseudopodium assembly (GO:0031272) | 4.90485459 |
| 21 | modified amino acid transport (GO:0072337) | 4.73409887 |
| 22 | glucose 6-phosphate metabolic process (GO:0051156) | 4.70409269 |
| 23 | response to hepatocyte growth factor (GO:0035728) | 4.68040807 |
| 24 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.68040807 |
| 25 | drinking behavior (GO:0042756) | 4.60853101 |
| 26 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.60510250 |
| 27 | lipoprotein metabolic process (GO:0042157) | 4.59838402 |
| 28 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.56352755 |
| 29 | innate immune response in mucosa (GO:0002227) | 4.44637502 |
| 30 | plasma lipoprotein particle assembly (GO:0034377) | 4.32599176 |
| 31 | flavonoid metabolic process (GO:0009812) | 4.31289613 |
| 32 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.30723600 |
| 33 | drug metabolic process (GO:0017144) | 4.28850908 |
| 34 | digestion (GO:0007586) | 4.27044180 |
| 35 | positive regulation of respiratory burst (GO:0060267) | 4.25255394 |
| 36 | intestinal epithelial cell development (GO:0060576) | 4.23261191 |
| 37 | peptide hormone processing (GO:0016486) | 4.18366966 |
| 38 | regulation of respiratory burst (GO:0060263) | 4.17235491 |
| 39 | protein-lipid complex assembly (GO:0065005) | 4.16475102 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.14164723 |
| 41 | hormone catabolic process (GO:0042447) | 4.14064825 |
| 42 | transepithelial transport (GO:0070633) | 4.13784534 |
| 43 | positive regulation of glycoprotein metabolic process (GO:1903020) | 4.11729156 |
| 44 | regulation of cGMP metabolic process (GO:0030823) | 4.10404571 |
| 45 | diacylglycerol metabolic process (GO:0046339) | 4.06750061 |
| 46 | membrane repolarization during action potential (GO:0086011) | 4.05970023 |
| 47 | thyroid hormone metabolic process (GO:0042403) | 4.02403488 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98029506 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 3.96882414 |
| 50 | regulation of vitamin metabolic process (GO:0030656) | 3.95587649 |
| 51 | renal system process involved in regulation of blood volume (GO:0001977) | 3.94564775 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 3.93063639 |
| 53 | glycolipid catabolic process (GO:0019377) | 3.92152513 |
| 54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.91923380 |
| 55 | * disruption of cells of other organism (GO:0044364) | 3.91805220 |
| 56 | * killing of cells of other organism (GO:0031640) | 3.91805220 |
| 57 | phospholipid efflux (GO:0033700) | 3.91373964 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.89633226 |
| 59 | lipoprotein transport (GO:0042953) | 3.85312593 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.84749367 |
| 61 | response to nitric oxide (GO:0071731) | 3.84290640 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 3.82787402 |
| 63 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.74794491 |
| 64 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.74794491 |
| 65 | cellular response to nitric oxide (GO:0071732) | 3.74362566 |
| 66 | cholesterol homeostasis (GO:0042632) | 3.73932557 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.73922572 |
| 68 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.72282527 |
| 69 | sterol homeostasis (GO:0055092) | 3.71479677 |
| 70 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.71469883 |
| 71 | regulation of cellular extravasation (GO:0002691) | 3.70732881 |
| 72 | * antimicrobial humoral response (GO:0019730) | 3.70270538 |
| 73 | mucosal immune response (GO:0002385) | 3.68635341 |
| 74 | filopodium assembly (GO:0046847) | 3.66501580 |
| 75 | NADH metabolic process (GO:0006734) | 3.66139498 |
| 76 | cholesterol transport (GO:0030301) | 3.66007271 |
| 77 | sterol transport (GO:0015918) | 3.66007271 |
| 78 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.65699697 |
| 79 | * antibacterial humoral response (GO:0019731) | 3.63539020 |
| 80 | sperm capacitation (GO:0048240) | 3.62199978 |
| 81 | cholesterol efflux (GO:0033344) | 3.60804932 |
| 82 | alkaloid metabolic process (GO:0009820) | 3.59667310 |
| 83 | arginine metabolic process (GO:0006525) | 3.58256834 |
| 84 | * defense response to fungus (GO:0050832) | 3.57867117 |
| 85 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.56470580 |
| 86 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.56470580 |
| 87 | endocrine process (GO:0050886) | 3.56470580 |
| 88 | glucuronate metabolic process (GO:0019585) | 3.55572253 |
| 89 | uronic acid metabolic process (GO:0006063) | 3.55572253 |
| 90 | sulfur compound transport (GO:0072348) | 3.54353202 |
| 91 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.52994774 |
| 92 | cellular glucuronidation (GO:0052695) | 3.52348514 |
| 93 | eosinophil chemotaxis (GO:0048245) | 3.51526366 |
| 94 | vitamin transmembrane transport (GO:0035461) | 3.51265796 |
| 95 | regulation of actin nucleation (GO:0051125) | 3.50333190 |
| 96 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.48660398 |
| 97 | organ or tissue specific immune response (GO:0002251) | 3.47110602 |
| 98 | glomerular filtration (GO:0003094) | 3.46573742 |
| 99 | peptide catabolic process (GO:0043171) | 3.46445959 |
| 100 | homocysteine metabolic process (GO:0050667) | 3.45224119 |
| 101 | vitamin transport (GO:0051180) | 3.42842728 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.37480772 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.37480772 |
| 104 | proline biosynthetic process (GO:0006561) | 3.36863767 |
| 105 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.36401084 |
| 106 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.33204948 |
| 107 | sulfate transmembrane transport (GO:1902358) | 3.32530444 |
| 108 | regulation of digestive system process (GO:0044058) | 3.31337599 |
| 109 | negative regulation of cholesterol transport (GO:0032375) | 3.27881079 |
| 110 | negative regulation of sterol transport (GO:0032372) | 3.27881079 |
| 111 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.27659084 |
| 112 | urea cycle (GO:0000050) | 3.27304594 |
| 113 | urea metabolic process (GO:0019627) | 3.27304594 |
| 114 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.27268952 |
| 115 | transcytosis (GO:0045056) | 3.25651126 |
| 116 | phospholipid scrambling (GO:0017121) | 3.24039127 |
| 117 | positive regulation of cGMP metabolic process (GO:0030825) | 3.23532366 |
| 118 | cellular response to reactive nitrogen species (GO:1902170) | 3.23195598 |
| 119 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.21697224 |
| 120 | cGMP-mediated signaling (GO:0019934) | 3.19923954 |
| 121 | regulation of systemic arterial blood pressure (GO:0003073) | 3.17568401 |
| 122 | complement activation, classical pathway (GO:0006958) | 3.16566162 |
| 123 | regulation of viral release from host cell (GO:1902186) | 3.16557045 |
| 124 | positive regulation of digestive system process (GO:0060456) | 3.16026478 |
| 125 | fat-soluble vitamin metabolic process (GO:0006775) | 3.15131041 |
| 126 | renal filtration (GO:0097205) | 3.14617071 |
| 127 | O-glycan processing (GO:0016266) | 3.13835843 |
| 128 | eosinophil migration (GO:0072677) | 3.12923580 |
| 129 | midgut development (GO:0007494) | 3.12790817 |
| 130 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.10674727 |
| 131 | regulation of chemokine secretion (GO:0090196) | 3.09890932 |
| 132 | phospholipid homeostasis (GO:0055091) | 3.07372668 |
| 133 | ceramide catabolic process (GO:0046514) | 3.07055650 |
| 134 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06878937 |
| 135 | bicarbonate transport (GO:0015701) | 3.06866537 |
| 136 | low-density lipoprotein particle remodeling (GO:0034374) | 3.05910509 |
| 137 | striated muscle atrophy (GO:0014891) | 3.04026983 |
| 138 | ethanol metabolic process (GO:0006067) | 3.03378179 |
| 139 | leukotriene metabolic process (GO:0006691) | 3.03070496 |
| 140 | cGMP biosynthetic process (GO:0006182) | 3.01037683 |
| 141 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.99523437 |
| 142 | GDP-mannose metabolic process (GO:0019673) | 2.98976244 |
| 143 | cobalamin metabolic process (GO:0009235) | 2.98287052 |
| 144 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.97905086 |
| 145 | sexual reproduction (GO:0019953) | 2.94995899 |
| 146 | desmosome organization (GO:0002934) | 2.93461769 |
| 147 | cardiac conduction (GO:0061337) | 2.90427035 |
| 148 | nitrogen cycle metabolic process (GO:0071941) | 2.89699979 |
| 149 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.88647248 |
| 150 | negative regulation of digestive system process (GO:0060457) | 2.88508374 |
| 151 | hepatocyte apoptotic process (GO:0097284) | 2.88390969 |
| 152 | intestinal cholesterol absorption (GO:0030299) | 12.2253164 |
| 153 | intestinal absorption (GO:0050892) | 12.0747199 |
| 154 | angiotensin maturation (GO:0002003) | 11.1543392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 6.17564902 |
| 2 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.98728245 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.66876167 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.55322250 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.48840036 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.32543531 |
| 7 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.31771070 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.87264862 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.87125725 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.71449572 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.53393546 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39748319 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.25193366 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13772816 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.03996995 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03904535 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.2955846 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97135557 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95209277 |
| 20 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.91126239 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.90472753 |
| 22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.89457758 |
| 23 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.85789401 |
| 24 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.75840084 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.74985016 |
| 26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.74286034 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72733218 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71148710 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68096013 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64360868 |
| 31 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60710808 |
| 32 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.58584851 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56249815 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54816611 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.54544243 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.52596994 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.50958281 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50921846 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48796091 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47149380 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46468857 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42685718 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41926525 |
| 44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41256593 |
| 45 | SA1_27219007_Chip-Seq_Bcells_Human | 1.40345959 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39999255 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.38596238 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35320788 |
| 49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33789929 |
| 50 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.31705675 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27601107 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27437039 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26593680 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26463296 |
| 55 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.25355425 |
| 56 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24064842 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23504607 |
| 58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23007581 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22920901 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22371113 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21892351 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20851440 |
| 63 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20492086 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19902235 |
| 65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19732956 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18983311 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18473854 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16810941 |
| 69 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15836866 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14997139 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14954063 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14225702 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12063745 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11961067 |
| 75 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.11267196 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10971756 |
| 77 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.09440004 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09169036 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07333549 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06993200 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06310083 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05843693 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05450410 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05044401 |
| 85 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04493689 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01801409 |
| 87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00536304 |
| 88 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99898722 |
| 89 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99834875 |
| 90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98846707 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98030175 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97870894 |
| 93 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97742245 |
| 94 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96174881 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95840526 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95702249 |
| 97 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.94983860 |
| 98 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94633426 |
| 99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94493184 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94482365 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94114100 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93680389 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93451526 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93437952 |
| 105 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93400033 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93369954 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91866334 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91550857 |
| 109 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90417217 |
| 110 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89878188 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89806336 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89806336 |
| 113 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89730071 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88026078 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87799602 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87442621 |
| 117 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87238585 |
| 118 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.86894160 |
| 119 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86724102 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86480359 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85783071 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84703166 |
| 123 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.84496053 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83298446 |
| 125 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83264518 |
| 126 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82397883 |
| 127 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.81258066 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80780043 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80432857 |
| 130 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.80431763 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79851535 |
| 132 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.79597601 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.78799553 |
| 134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78436836 |
| 135 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77674493 |
| 136 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76987193 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75956630 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74730204 |
| 139 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73954224 |
| 140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73412260 |
| 141 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73220062 |
| 142 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.71775300 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71774530 |
| 144 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.70815500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.98820807 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.57645941 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.97574680 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.81181460 |
| 5 | MP0009840_abnormal_foam_cell | 3.79017848 |
| 6 | MP0000462_abnormal_digestive_system | 3.75621898 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.72823482 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.71830734 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.46176979 |
| 10 | MP0009379_abnormal_foot_pigmentation | 3.07636559 |
| 11 | MP0003866_abnormal_defecation | 2.61878080 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.45760533 |
| 13 | MP0003252_abnormal_bile_duct | 2.41006593 |
| 14 | MP0002822_catalepsy | 2.40566246 |
| 15 | MP0005365_abnormal_bile_salt | 2.37889939 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.29823922 |
| 17 | MP0008004_abnormal_stomach_pH | 2.20177031 |
| 18 | MP0000537_abnormal_urethra_morphology | 2.19625802 |
| 19 | MP0000538_abnormal_urinary_bladder | 2.10264266 |
| 20 | MP0005409_darkened_coat_color | 2.09025409 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.92967183 |
| 22 | MP0001873_stomach_inflammation | 1.91523849 |
| 23 | MP0005381_digestive/alimentary_phenotyp | 1.91398500 |
| 24 | MP0001663_abnormal_digestive_system | 1.90595102 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85601651 |
| 26 | MP0005084_abnormal_gallbladder_morpholo | 1.84907462 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.82602985 |
| 28 | MP0001664_abnormal_digestion | 1.82380656 |
| 29 | MP0004858_abnormal_nervous_system | 1.81957822 |
| 30 | MP0004147_increased_porphyrin_level | 1.66040606 |
| 31 | MP0005377_hearing/vestibular/ear_phenot | 1.63228024 |
| 32 | MP0003878_abnormal_ear_physiology | 1.63228024 |
| 33 | MP0000490_abnormal_crypts_of | 1.62429026 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.58608182 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.56670287 |
| 36 | MP0000477_abnormal_intestine_morphology | 1.51125701 |
| 37 | MP0005448_abnormal_energy_balance | 1.41274282 |
| 38 | MP0004782_abnormal_surfactant_physiolog | 1.39702441 |
| 39 | MP0001188_hyperpigmentation | 1.33311596 |
| 40 | MP0002796_impaired_skin_barrier | 1.32692623 |
| 41 | MP0002254_reproductive_system_inflammat | 1.29725623 |
| 42 | MP0002089_abnormal_postnatal_growth/wei | 1.28915262 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.18854215 |
| 44 | MP0008872_abnormal_physiological_respon | 1.16884459 |
| 45 | MP0003724_increased_susceptibility_to | 1.16085215 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.15958299 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.13119468 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.11584842 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.07692608 |
| 50 | MP0005387_immune_system_phenotype | 1.04773285 |
| 51 | MP0001790_abnormal_immune_system | 1.04773285 |
| 52 | MP0005332_abnormal_amino_acid | 1.04303039 |
| 53 | MP0009785_altered_susceptibility_to | 1.03143855 |
| 54 | MP0003436_decreased_susceptibility_to | 1.02986064 |
| 55 | MP0002166_altered_tumor_susceptibility | 0.97349315 |
| 56 | MP0005025_abnormal_response_to | 0.96428856 |
| 57 | MP0001756_abnormal_urination | 0.95296285 |
| 58 | MP0005174_abnormal_tail_pigmentation | 0.94871043 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 0.94309652 |
| 60 | MP0001849_ear_inflammation | 0.93751601 |
| 61 | MP0005535_abnormal_body_temperature | 0.93706057 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 0.92445383 |
| 63 | MP0005670_abnormal_white_adipose | 0.92057905 |
| 64 | MP0000613_abnormal_salivary_gland | 0.89254399 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 0.88805788 |
| 66 | MP0001485_abnormal_pinna_reflex | 0.87972662 |
| 67 | MP0003303_peritoneal_inflammation | 0.87911887 |
| 68 | MP0006054_spinal_hemorrhage | 0.87365449 |
| 69 | MP0004270_analgesia | 0.87174203 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 0.86756619 |
| 71 | MP0002971_abnormal_brown_adipose | 0.86356733 |
| 72 | MP0000678_abnormal_parathyroid_gland | 0.86277667 |
| 73 | MP0010678_abnormal_skin_adnexa | 0.86170759 |
| 74 | MP0005501_abnormal_skin_physiology | 0.85778777 |
| 75 | MP0003329_amyloid_beta_deposits | 0.84355335 |
| 76 | MP0000609_abnormal_liver_physiology | 0.83659950 |
| 77 | MP0004043_abnormal_pH_regulation | 0.82126891 |
| 78 | MP0000604_amyloidosis | 0.81802138 |
| 79 | MP0004947_skin_inflammation | 0.80847443 |
| 80 | MP0002098_abnormal_vibrissa_morphology | 0.80735658 |
| 81 | MP0005671_abnormal_response_to | 0.80481343 |
| 82 | MP0008469_abnormal_protein_level | 0.79501200 |
| 83 | MP0006082_CNS_inflammation | 0.77646133 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.76228975 |
| 85 | MP0005166_decreased_susceptibility_to | 0.75154948 |
| 86 | MP0009764_decreased_sensitivity_to | 0.74190712 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.73978700 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.73910963 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.73172073 |
| 90 | MP0009115_abnormal_fat_cell | 0.72851641 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.72622638 |
| 92 | MP0003868_abnormal_feces_composition | 0.72125528 |
| 93 | MP0003938_abnormal_ear_development | 0.70742958 |
| 94 | MP0000685_abnormal_immune_system | 0.69479580 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.69267087 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.68683065 |
| 97 | MP0000249_abnormal_blood_vessel | 0.67007454 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 0.66528528 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.66072553 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.65328607 |
| 101 | MP0001800_abnormal_humoral_immune | 0.64643643 |
| 102 | MP0003119_abnormal_digestive_system | 0.64131249 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.63717194 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.63080137 |
| 105 | MP0000470_abnormal_stomach_morphology | 0.63004297 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.62690513 |
| 107 | MP0003693_abnormal_embryo_hatching | 0.62329650 |
| 108 | MP0000467_abnormal_esophagus_morphology | 0.62276238 |
| 109 | MP0003315_abnormal_perineum_morphology | 0.61187952 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.60835484 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.60404008 |
| 112 | MP0002006_tumorigenesis | 0.59399304 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.58441893 |
| 114 | MP0000013_abnormal_adipose_tissue | 0.58367396 |
| 115 | MP0001764_abnormal_homeostasis | 0.57804189 |
| 116 | MP0005165_increased_susceptibility_to | 0.57736717 |
| 117 | MP0001881_abnormal_mammary_gland | 0.57420143 |
| 118 | MP0009053_abnormal_anal_canal | 0.56255542 |
| 119 | MP0005000_abnormal_immune_tolerance | 0.55748943 |
| 120 | MP0003879_abnormal_hair_cell | 0.55424543 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.54764510 |
| 122 | MP0000566_synostosis | 0.53958811 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.51647858 |
| 124 | MP0005310_abnormal_salivary_gland | 0.51296744 |
| 125 | MP0003718_maternal_effect | 0.51091986 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.50017935 |
| 127 | MP0000579_abnormal_nail_morphology | 0.49729152 |
| 128 | MP0003283_abnormal_digestive_organ | 0.49296569 |
| 129 | MP0002060_abnormal_skin_morphology | 0.46867134 |
| 130 | MP0000516_abnormal_urinary_system | 0.46623042 |
| 131 | MP0005367_renal/urinary_system_phenotyp | 0.46623042 |
| 132 | MP0003787_abnormal_imprinting | 0.45472832 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.44248944 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.43558833 |
| 135 | MP0002163_abnormal_gland_morphology | 0.43149246 |
| 136 | MP0010771_integument_phenotype | 0.42856338 |
| 137 | MP0009697_abnormal_copulation | 0.42262813 |
| 138 | MP0000377_abnormal_hair_follicle | 0.42205687 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.40946204 |
| 140 | MP0005451_abnormal_body_composition | 0.38651475 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.38518361 |
| 142 | MP0006138_congestive_heart_failure | 0.34404334 |
| 143 | MP0005023_abnormal_wound_healing | 0.31639888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.62575634 |
| 2 | Malnutrition (HP:0004395) | 5.81089332 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.64685178 |
| 4 | Acanthocytosis (HP:0001927) | 5.48699634 |
| 5 | Ventricular fibrillation (HP:0001663) | 5.29904137 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 5.29783454 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.29033132 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.21593234 |
| 9 | Hydroxyprolinuria (HP:0003080) | 5.05326031 |
| 10 | Abnormality of proline metabolism (HP:0010907) | 5.05326031 |
| 11 | Congenital sensorineural hearing impairment (HP:0008527) | 4.84253594 |
| 12 | Fat malabsorption (HP:0002630) | 4.19650816 |
| 13 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.00693268 |
| 14 | Widely patent fontanelles and sutures (HP:0004492) | 3.86133913 |
| 15 | Abnormality of vitamin B metabolism (HP:0004340) | 3.73243126 |
| 16 | Rectal prolapse (HP:0002035) | 3.63932887 |
| 17 | Pustule (HP:0200039) | 3.56653555 |
| 18 | Proximal tubulopathy (HP:0000114) | 3.48956147 |
| 19 | Gastrointestinal dysmotility (HP:0002579) | 3.46421469 |
| 20 | Hyperglycinuria (HP:0003108) | 3.42537038 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.39198357 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.37880780 |
| 23 | Pigmentary retinal degeneration (HP:0001146) | 3.34731745 |
| 24 | Abdominal distention (HP:0003270) | 3.30738336 |
| 25 | Decreased circulating renin level (HP:0003351) | 3.22879368 |
| 26 | Abnormality of vitamin metabolism (HP:0100508) | 3.21874752 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 3.20938420 |
| 28 | Glycosuria (HP:0003076) | 3.20938420 |
| 29 | Poikilocytosis (HP:0004447) | 3.20079715 |
| 30 | Wide cranial sutures (HP:0010537) | 3.16298124 |
| 31 | Eczematoid dermatitis (HP:0000976) | 3.15593352 |
| 32 | Syncope (HP:0001279) | 3.15191326 |
| 33 | Chronic diarrhea (HP:0002028) | 3.11777231 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.09289865 |
| 35 | Alkalosis (HP:0001948) | 3.03357845 |
| 36 | Abnormal biliary tract morphology (HP:0012440) | 3.02354517 |
| 37 | Hypolipoproteinemia (HP:0010981) | 2.98705124 |
| 38 | Metabolic alkalosis (HP:0200114) | 2.97932473 |
| 39 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.97530706 |
| 40 | Villous atrophy (HP:0011473) | 2.97530706 |
| 41 | Increased purine levels (HP:0004368) | 2.93619931 |
| 42 | Hyperuricemia (HP:0002149) | 2.93619931 |
| 43 | Goiter (HP:0000853) | 2.89959165 |
| 44 | Steatorrhea (HP:0002570) | 2.86710080 |
| 45 | Confusion (HP:0001289) | 2.86402147 |
| 46 | Hyperphosphaturia (HP:0003109) | 2.86099187 |
| 47 | Glomerulonephritis (HP:0000099) | 2.85048921 |
| 48 | Prolonged QT interval (HP:0001657) | 2.80799667 |
| 49 | Progressive hearing impairment (HP:0001730) | 2.76619159 |
| 50 | Abnormality of complement system (HP:0005339) | 2.75524049 |
| 51 | Pili torti (HP:0003777) | 2.75346109 |
| 52 | Increased mean platelet volume (HP:0011877) | 2.71442441 |
| 53 | Megaloblastic anemia (HP:0001889) | 2.71032716 |
| 54 | Nephrolithiasis (HP:0000787) | 2.69211298 |
| 55 | Abnormality of the gastric mucosa (HP:0004295) | 2.66981191 |
| 56 | Fragile skin (HP:0001030) | 2.65493464 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.63307727 |
| 58 | Urethral obstruction (HP:0000796) | 2.62863567 |
| 59 | Milia (HP:0001056) | 2.61219348 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.60383954 |
| 61 | Complement deficiency (HP:0004431) | 2.59614451 |
| 62 | Hyperactive renin-angiotensin system (HP:0000841) | 2.55720492 |
| 63 | Dehydration (HP:0001944) | 2.55615556 |
| 64 | Potter facies (HP:0002009) | 2.55390438 |
| 65 | Facial shape deformation (HP:0011334) | 2.55390438 |
| 66 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.54116621 |
| 67 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.50489956 |
| 68 | Cupped ribs (HP:0000887) | 2.46296501 |
| 69 | Nephritis (HP:0000123) | 2.44886238 |
| 70 | Progressive sensorineural hearing impairment (HP:0000408) | 2.44588839 |
| 71 | Cheilitis (HP:0100825) | 2.42450239 |
| 72 | Abnormal urine phosphate concentration (HP:0012599) | 2.40833702 |
| 73 | Hemorrhage of the eye (HP:0011885) | 2.40771278 |
| 74 | Abnormality of renin-angiotensin system (HP:0000847) | 2.40627867 |
| 75 | Abnormal platelet volume (HP:0011876) | 2.36011013 |
| 76 | Woolly hair (HP:0002224) | 2.35626502 |
| 77 | Thin bony cortex (HP:0002753) | 2.35155962 |
| 78 | Hypotension (HP:0002615) | 2.34634716 |
| 79 | Palpitations (HP:0001962) | 2.32481804 |
| 80 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.32036309 |
| 81 | Abnormality of glycine metabolism (HP:0010895) | 2.32036309 |
| 82 | Enlarged epiphyses (HP:0010580) | 2.30207784 |
| 83 | Cerebral palsy (HP:0100021) | 2.27434484 |
| 84 | Biliary tract neoplasm (HP:0100574) | 2.27328461 |
| 85 | Abnormal hemoglobin (HP:0011902) | 2.26546427 |
| 86 | Ventricular arrhythmia (HP:0004308) | 2.25758104 |
| 87 | Hypercholesterolemia (HP:0003124) | 2.24425077 |
| 88 | Pancreatitis (HP:0001733) | 2.21853799 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.20647559 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20647559 |
| 91 | Delayed epiphyseal ossification (HP:0002663) | 2.19591455 |
| 92 | Focal segmental glomerulosclerosis (HP:0000097) | 2.18850562 |
| 93 | Gingivitis (HP:0000230) | 2.18667843 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.18584273 |
| 95 | Hyperparathyroidism (HP:0000843) | 2.17669533 |
| 96 | Hyperphosphatemia (HP:0002905) | 2.16192641 |
| 97 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13864303 |
| 98 | Abnormal glucose tolerance (HP:0001952) | 2.12788605 |
| 99 | Myopathic facies (HP:0002058) | 2.12013947 |
| 100 | Late onset (HP:0003584) | 2.10327881 |
| 101 | Growth hormone excess (HP:0000845) | 2.09675194 |
| 102 | Abnormality of the costochondral junction (HP:0000919) | 2.06810961 |
| 103 | Nausea (HP:0002018) | 2.04035999 |
| 104 | Reticulocytosis (HP:0001923) | 2.03340256 |
| 105 | Micronodular cirrhosis (HP:0001413) | 2.01938742 |
| 106 | Posterior subcapsular cataract (HP:0007787) | 2.00730934 |
| 107 | Male infertility (HP:0003251) | 2.00376329 |
| 108 | Symptomatic seizures (HP:0011145) | 2.00351642 |
| 109 | Ileus (HP:0002595) | 10.1288422 |
| 110 | Subcapsular cataract (HP:0000523) | 1.98447962 |
| 111 | Renal tubular acidosis (HP:0001947) | 1.98091944 |
| 112 | Protuberant abdomen (HP:0001538) | 1.96805333 |
| 113 | Hyperbilirubinemia (HP:0002904) | 1.96264517 |
| 114 | Epidermoid cyst (HP:0200040) | 1.95605247 |
| 115 | Hyperammonemia (HP:0001987) | 1.95559121 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.93470703 |
| 117 | Gastrointestinal stroma tumor (HP:0100723) | 1.92323634 |
| 118 | Ankyloglossia (HP:0010296) | 1.92170404 |
| 119 | Gout (HP:0001997) | 1.91637401 |
| 120 | Abnormal EKG (HP:0003115) | 1.90723261 |
| 121 | Abnormality of magnesium homeostasis (HP:0004921) | 1.90449645 |
| 122 | Abnormal hair laboratory examination (HP:0003328) | 1.89006989 |
| 123 | Irritability (HP:0000737) | 1.88577512 |
| 124 | Abnormality of chloride homeostasis (HP:0011422) | 1.87664425 |
| 125 | Xanthomatosis (HP:0000991) | 1.87505646 |
| 126 | Emphysema (HP:0002097) | 1.83029995 |
| 127 | Multiple lipomas (HP:0001012) | 1.81857315 |
| 128 | Plantar hyperkeratosis (HP:0007556) | 1.80573916 |
| 129 | Uterine neoplasm (HP:0010784) | 1.80238149 |
| 130 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79492977 |
| 131 | Hypophosphatemia (HP:0002148) | 1.78250672 |
| 132 | Paresthesia (HP:0003401) | 1.77762684 |
| 133 | Petechiae (HP:0000967) | 1.77125955 |
| 134 | Hypoalbuminemia (HP:0003073) | 1.76931243 |
| 135 | Abnormal albumin level (HP:0012116) | 1.76931243 |
| 136 | Premature loss of primary teeth (HP:0006323) | 1.76781097 |
| 137 | Macrocytic anemia (HP:0001972) | 1.76323667 |
| 138 | Skin rash (HP:0000988) | 1.75864446 |
| 139 | Metabolic acidosis (HP:0001942) | 1.75433216 |
| 140 | Increased muscle lipid content (HP:0009058) | 1.75172780 |
| 141 | Flat acetabular roof (HP:0003180) | 1.73674590 |
| 142 | Ventricular tachycardia (HP:0004756) | 1.73047690 |
| 143 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72336023 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72328485 |
| 145 | Hypocalcemia (HP:0002901) | 1.70111349 |
| 146 | Abnormality of reticulocytes (HP:0004312) | 1.69651234 |
| 147 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.68117966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.31595564 |
| 2 | LMTK2 | 6.98084159 |
| 3 | FRK | 6.11973197 |
| 4 | MST4 | 4.68295501 |
| 5 | MST1R | 3.83056226 |
| 6 | NME1 | 3.68522589 |
| 7 | PRKG2 | 3.65028037 |
| 8 | GRK6 | 3.04029828 |
| 9 | EPHA2 | 2.90932031 |
| 10 | MAP2K6 | 2.44103455 |
| 11 | RIPK1 | 2.43954447 |
| 12 | MAP2K2 | 2.42997015 |
| 13 | TAOK3 | 2.36695244 |
| 14 | EIF2AK1 | 2.34796256 |
| 15 | EPHB2 | 2.30337505 |
| 16 | NUAK1 | 2.15565003 |
| 17 | TYK2 | 2.15145447 |
| 18 | EPHA3 | 1.89863182 |
| 19 | MAP3K10 | 1.88851111 |
| 20 | PTK6 | 1.71699355 |
| 21 | MAP3K2 | 1.65638526 |
| 22 | AKT3 | 1.42802074 |
| 23 | MET | 1.38836529 |
| 24 | ERN1 | 1.37959569 |
| 25 | DMPK | 1.30009815 |
| 26 | MAP3K9 | 1.23284395 |
| 27 | PRPF4B | 1.23191377 |
| 28 | MAP3K11 | 1.23083143 |
| 29 | PDK2 | 1.22607030 |
| 30 | ERBB2 | 1.17392429 |
| 31 | PBK | 1.17318027 |
| 32 | FGFR3 | 1.13615353 |
| 33 | STK24 | 1.08367379 |
| 34 | CDC42BPA | 1.06842182 |
| 35 | TNIK | 1.03593020 |
| 36 | STK39 | 1.02539957 |
| 37 | PIK3CA | 1.02116313 |
| 38 | TLK1 | 0.97847300 |
| 39 | TESK1 | 0.95247352 |
| 40 | NLK | 0.93015490 |
| 41 | MAP3K8 | 0.90071992 |
| 42 | TAOK1 | 0.89603385 |
| 43 | EPHA4 | 0.88504338 |
| 44 | TTK | 0.87524149 |
| 45 | STK10 | 0.85760012 |
| 46 | PTK2 | 0.85725987 |
| 47 | MAP3K1 | 0.83259458 |
| 48 | IKBKE | 0.78108915 |
| 49 | MAPK11 | 0.75572797 |
| 50 | JAK1 | 0.73250450 |
| 51 | KSR2 | 0.72290694 |
| 52 | IRAK3 | 0.69457350 |
| 53 | FER | 0.66826296 |
| 54 | MYLK | 0.66631069 |
| 55 | MAP2K1 | 0.65657371 |
| 56 | PRKCI | 0.65309772 |
| 57 | MATK | 0.64284498 |
| 58 | ZAP70 | 0.63932628 |
| 59 | DDR2 | 0.63808671 |
| 60 | IRAK1 | 0.63284641 |
| 61 | JAK3 | 0.61737856 |
| 62 | RIPK4 | 0.60302221 |
| 63 | PRKAA2 | 0.59857058 |
| 64 | EPHB1 | 0.59472839 |
| 65 | MAP4K1 | 0.59334947 |
| 66 | TBK1 | 0.59010151 |
| 67 | PRKCZ | 0.58973581 |
| 68 | JAK2 | 0.58112630 |
| 69 | AURKB | 0.56290953 |
| 70 | WNK4 | 0.54810751 |
| 71 | TRIB3 | 0.54163199 |
| 72 | KIT | 0.52423708 |
| 73 | BMPR2 | 0.49897835 |
| 74 | PIM1 | 0.49745590 |
| 75 | CSF1R | 0.49615087 |
| 76 | BMX | 0.48621392 |
| 77 | SMG1 | 0.46526703 |
| 78 | SYK | 0.46314356 |
| 79 | BTK | 0.46223942 |
| 80 | MAP3K3 | 0.45986651 |
| 81 | PDGFRA | 0.45903860 |
| 82 | ABL2 | 0.45286882 |
| 83 | RET | 0.44761466 |
| 84 | CAMK2B | 0.42583194 |
| 85 | MAP3K7 | 0.42324346 |
| 86 | MAP3K14 | 0.42137308 |
| 87 | CAMK2D | 0.41828243 |
| 88 | GRK1 | 0.41745766 |
| 89 | CDK19 | 0.40471045 |
| 90 | PAK4 | 0.40314509 |
| 91 | ITK | 0.38332352 |
| 92 | ROCK1 | 0.38036888 |
| 93 | MAPK15 | 0.37919205 |
| 94 | KDR | 0.36972610 |
| 95 | LYN | 0.36604215 |
| 96 | CAMK2G | 0.35300312 |
| 97 | CDK6 | 0.34662376 |
| 98 | IRAK4 | 0.34366312 |
| 99 | OXSR1 | 0.33267061 |
| 100 | YES1 | 0.32995363 |
| 101 | CSNK1E | 0.32797373 |
| 102 | CASK | 0.32341645 |
| 103 | LCK | 0.32337400 |
| 104 | LATS1 | 0.32128978 |
| 105 | TGFBR2 | 0.30720309 |
| 106 | PAK3 | 0.30314306 |
| 107 | CDK12 | 0.30122329 |
| 108 | FGFR4 | 0.30018276 |
| 109 | PAK1 | 0.29505262 |
| 110 | PRKCA | 0.29171072 |
| 111 | BCR | 0.28761697 |
| 112 | SRC | 0.26065006 |
| 113 | TEC | 0.26050401 |
| 114 | BLK | 0.26008234 |
| 115 | LRRK2 | 0.25290488 |
| 116 | PRKAA1 | 0.24821979 |
| 117 | RPS6KA2 | 0.24648906 |
| 118 | PDPK1 | 0.23714286 |
| 119 | PRKACG | 0.22096941 |
| 120 | CSNK1A1 | 0.21735679 |
| 121 | PRKCQ | 0.21723149 |
| 122 | SCYL2 | 0.18808041 |
| 123 | PRKCD | 0.18280956 |
| 124 | MAP3K12 | 0.18135305 |
| 125 | RAF1 | 0.16972977 |
| 126 | KSR1 | 0.16523823 |
| 127 | PAK2 | 0.16507725 |
| 128 | FYN | 0.14290704 |
| 129 | DYRK1B | 0.13615742 |
| 130 | RPS6KB2 | 0.13314768 |
| 131 | AKT2 | 0.12608058 |
| 132 | TESK2 | 0.12460187 |
| 133 | CSK | 0.11556428 |
| 134 | PDK1 | 0.10980197 |
| 135 | PRKCB | 0.10656697 |
| 136 | MAPKAPK2 | 0.10362815 |
| 137 | EEF2K | 0.09027856 |
| 138 | CDK5 | 0.08071340 |
| 139 | CHUK | 0.08049759 |
| 140 | STK11 | 0.07907763 |
| 141 | PRKG1 | 0.06781954 |
| 142 | RPS6KA4 | 0.06234285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.24204884 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.36635776 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.56536483 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.59384555 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 3.37864015 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.69807253 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.52529124 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.43826389 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.40390007 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.33459362 |
| 11 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.27074342 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26278537 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.09700355 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.01401806 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.87951066 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75987224 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74639741 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65296621 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.58136933 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55894790 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55446600 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.54517546 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.50722956 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.50147595 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44971701 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42868092 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.42300986 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41498925 |
| 29 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.34841109 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34040684 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27955146 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22951541 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22903224 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.19536742 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16774377 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.15730690 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12378079 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10245063 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08304241 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03751742 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00273239 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97745700 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95812178 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95290475 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.92110069 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92092527 |
| 47 | Tight junction_Homo sapiens_hsa04530 | 0.90397776 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89729546 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88577099 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86943779 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80847024 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78791245 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76770731 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75307441 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.75301277 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74880547 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72591212 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72205635 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67091256 |
| 60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65291381 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60982801 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57072045 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56132697 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.54261367 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53981270 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52333891 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.52296437 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51255333 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46560119 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46058876 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44842642 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42034195 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.41174443 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41123041 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39699077 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39573924 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36953873 |
| 78 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36837196 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35798513 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35635902 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35423177 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34820631 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.34054137 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33015490 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32861536 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32330850 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32136430 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31879455 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.30966261 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.30697591 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29918398 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29506836 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29137116 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28819158 |
| 95 | Ribosome_Homo sapiens_hsa03010 | 0.28077134 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.27179512 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26520746 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.26512767 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25879255 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25682368 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.25300549 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.25155480 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24517854 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23940096 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23110103 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22842808 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22595484 |
| 108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21759944 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.21452602 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20790020 |
| 111 | Renin secretion_Homo sapiens_hsa04924 | 0.20364892 |
| 112 | Tuberculosis_Homo sapiens_hsa05152 | 0.19806568 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18850584 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.17832684 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16982954 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16038685 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16003154 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14195925 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13890696 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.12665142 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.12568731 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12344883 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.12092033 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.10503739 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.10332461 |
| 126 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.09134768 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.08156590 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07078222 |
| 129 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.06396677 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.05381138 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.04622916 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04514321 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.03805156 |
| 134 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.03403822 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.01877119 |

